SALE
市場調查報告書

動物用醫藥品的全球市場:各類型產品 、各產品(外部寄生蟲驅除劑,內部寄生蟲驅除劑,抗發炎藥,支氣管擴張藥),動物的各類型、各登記、各地區的預測和機會

Global Animal Pharmaceuticals Market By Product Type, By Product (Ectoparasiticides, Endoparasiticides, Anti-Inflammatories, Bronchodilators ), By Animal Type, By Registration, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 934730
出版日期 內容資訊 英文 114 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

動物用醫藥品的全球市場:各類型產品 、各產品(外部寄生蟲驅除劑,內部寄生蟲驅除劑,抗發炎藥,支氣管擴張藥),動物的各類型、各登記、各地區的預測和機會 Global Animal Pharmaceuticals Market By Product Type, By Product (Ectoparasiticides, Endoparasiticides, Anti-Inflammatories, Bronchodilators ), By Animal Type, By Registration, By Region, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 114 Pages
簡介

動物用醫藥品的市場,大致區分為寵物用和產業動物用,前者的市場佔著很大的佔有率。北美地區是最大的市場,畜產繁盛,寵物的飼養數也多,亞太地區的市場也急速成長。各國政府的動物實驗相關法規的強化,電子商務平台銷售的假藥等問題,雖然成為阻礙成長的要素於,但是市場預測到2025年繼續踏實成長。

本報告提供全球動物用醫藥品市場調查,各地區市場展望,市場力學與趨勢,競爭情形和主要企業的簡介等資訊,同時再加上策略性建議。

目錄

第1章 產品概要

第2章 調查方法

第3章 摘要整理

第4章 客戶的迴響

第5章 全球市場的展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各類型產品 (疫苗,獸醫用醫藥品,其他)
    • 各產品
    • 動物的各類型(寵物,產業動物)
    • 各登記(學名藥,專利藥)
    • 各地區(亞太地區,歐洲、 北美,南美,中東、非洲)
    • 各企業(2019年)
  • 產品市場地圖

第6章 亞太地區市場展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各類型產品
    • 各產品
    • 動物的各類型
    • 各國
  • 亞太地區:各國分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第7章 歐洲市場展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各類型產品
    • 各產品
    • 動物的各類型
    • 各國
  • 歐洲:各國分析
    • 英國
    • 義大利
    • 法國
    • 德國
    • 西班牙

第8章 北美市場展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各類型產品
    • 各產品
    • 動物的各類型
    • 各國
  • 北美:各國分析
    • 美國
    • 加拿大
    • 墨西哥

第9章 南美市場展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各類型產品
    • 各產品
    • 動物的各類型
    • 各國
  • 南美:各國分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章 中東、非洲市場展望

  • 市場規模與預測
    • 以金額為準和以數量為準
  • 市場佔有率與預測
    • 各類型產品
    • 各產品
    • 動物的各類型
    • 各國
  • 中東、非洲:各國分析
    • UAE
    • 沙烏地阿拉伯
    • 卡達
    • 南非

第11章 市場力學

  • 促進促進因素
  • 課題

第12章 市場趨勢

第13章 價格分析

第14章 專利/ FDA的認證相關分析

  • 新產品開發(核准申請狀況)
  • 各企業
  • 登記日
  • 專利到期

第15章 競爭情形

  • 主要企業的簡介
    • Zoetis Inc
    • Merck Animal Health
    • Vetoquinol SA
    • Zoetis Inc
    • Virbac SA
    • Boehringer Ingelheim International GmbH
    • Eli Lilly & Co
    • Perrigo Co PLC
    • Sanofi SA
    • Bayer AG
    • Elanco Animal Health Inc
    • Ceva Sante Animale S.A.
    • Covetrus Inc.
    • Idexx Laboratories Inc.
    • Vetoquinol USA, Inc.
    • Norbrook Laboratories, Ltd.
    • Huvepharma EOOD
    • Adivo GmbH
    • Ceva Sant Animale
    • Phibro Animal Health Corp.

第16章 策略性建議

第17章 免責聲明

目錄
Product Code: 4543

The market for animal pharmaceuticals market is likely to grow with a steady CAGR during the forecast period due to the increase in pet adoption, rise in fatal diseases like Ebola and swine flu spreading from consumption of dairy and animal related products. Animal pharmaceuticals are highly beneficial in diagnosis and treatment of animal disorders. The restraining factors for the market can be the government rules regarding animal testing, and the probability of sales of fake medicines across e-commerce platforms.

The global animal pharmaceuticals market is segmented on the basis of product type, product, animal type, registration and region. Based on animal type, the market is segmented into companion and production animals. Companion animals tend to hold a larger share in the market as pet owners are concerned for their pet's health and well-being. As compared to production animals, companion animals receive special care and veterinary treatment from their owners, which is the major factor driving the market share of this segment.

The overall animal pharmaceuticals market is widespread, expanding itself to Asia-Pacific, Europe, North America, South America, and Middle East & Africa. North America holds the largest market share by virtue of the pre-existing established pharmaceutical companies and the increasing consumption of meat and milk in the region. However, fastest growth is shown by the Asia-Pacific sector due to export of animals to other countries. Export process involves testing of the animals with which farm owners need to comply with therefore, the region is expected to witness highest growth over the next five years.

Major players of the animal pharmaceuticals market include Zoetis Inc, Merck Animal Health, Vetoquinol SA, Zoetis Inc, Virbac SA, Boehringer Ingelheim International GmbH, Eli Lilly & Co, Perrigo Co PLC, Sanofi SA, Bayer AG, Elanco Animal Health Inc, Ceva Sante Animale S.A., Covetrus Inc., Idexx Laboratories Inc., Vetoquinol USA, Inc., Norbrook Laboratories, Ltd., Huvepharma EOOD, Adivo GmbH, Ceva Sant Animale, Phibro Animal Health Corp, etc. The inter-company competition keeps on increasing parallelly with the market which in turn leads to innovations in technology, thus enhancing animal healthcare sector.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global animal pharmaceuticals market.
  • To classify and forecast global animal pharmaceuticals market based on product type, product, animal type, registration and region.
  • To identify drivers and challenges for global animal pharmaceuticals market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global animal pharmaceuticals market.
  • To conduct pricing analysis for global animal pharmaceuticals market.
  • To identify and analyze the profile of leading players operating in global animal pharmaceuticals market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global animal pharmaceuticals market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Manufacturers, suppliers of medicines, distributors and other stakeholders
  • Animal healthcare centers, vets
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to animal pharmaceuticals
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global animal pharmaceuticals market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Product Type:

Vaccine

Veterinary

Others

  • Market, By Product:

Ectoparasiticides

  • Ivermectin
  • Cypermethrin
  • Fipronil
  • Coumaphos
  • Others

Endoparasiticides

  • Ivermectin
  • Praziquantel
  • Flubendazol
  • Milbemycin
  • Levamisole
  • Fenbendazole
  • Pyrantel
  • Others

Anti-Inflammatories

  • NSAIDs
  • Corticosteroids
  • Others

Bronchodilators

  • Theophylline
  • Albuterol
  • Others
  • Market, By Animal Type:

Companion Animals

Production Animals

  • Market, By Registration:

Generic

Patented

  • Market, By Region:

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Europe

  • United Kingdom
  • Italy
  • France
  • Germany
  • Spain

North America

  • United States
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global animal pharmaceuticals market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customers

5. Global Animal Pharmaceuticals Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Vaccine, Veterinary, Others)
    • 5.2.2. By Product
      • 5.2.2.1. Ectoparasiticides (Ivermectin, Cypermethrin, Fipronil, Coumaphos, Others)
      • 5.2.2.2. Endoparasiticides (Ivermectin, Praziquantel, Flubendazole, Milbemycin, Levamisole, Fenbendazole, Pyrantel, Others)
      • 5.2.2.3. Anti-Inflammatories (NSAIDs, Corticosteroids, Others)
      • 5.2.2.4. Bronchodilators (Theophylline, Albuterol, Others)
    • 5.2.3. By Animal Type (Companion Animals, Production Animals)
    • 5.2.4. By Registration (Generic, Patented)
    • 5.2.5. By Region (Asia-Pacific, Europe, North America, South America, MEA)
    • 5.2.6. By Company (2019)
  • 5.3. Product Market Map

6. Asia-Pacific Animal Pharmaceuticals Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Product
    • 6.2.3. By Animal Type
    • 6.2.4. By Country (China; India; Japan; South Korea; Australia)
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Animal Pharmaceuticals Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value & Volume
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Animal Type
    • 6.3.2. India Animal Pharmaceuticals Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value & Volume
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Animal Type
    • 6.3.3. Japan Animal Pharmaceuticals Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value & Volume
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Animal Type
    • 6.3.4. South Korea Animal Pharmaceuticals Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value & Volume
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product Type
        • 6.3.4.2.2. By Product
        • 6.3.4.2.3. By Animal Type
    • 6.3.5. Australia Animal Pharmaceuticals Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value & Volume
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product Type
        • 6.3.5.2.2. By Product
        • 6.3.5.2.3. By Animal Type

7. Europe Animal Pharmaceuticals Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Product
    • 7.2.3. By Animal Type
    • 7.2.4. By Country (United Kingdom; Italy; France; Germany; Spain)
  • 7.3. Europe: Country Analysis
    • 7.3.1. United Kingdom Animal Pharmaceuticals Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Animal Type
    • 7.3.2. Italy Animal Pharmaceuticals Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Animal Type
    • 7.3.3. France Animal Pharmaceuticals Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Animal Type
    • 7.3.4. Germany Animal Pharmaceuticals Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value & Volume
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Animal Type
    • 7.3.5. Spain Animal Pharmaceuticals Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value & Volume
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Animal Type

8. North America Animal Pharmaceuticals Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Product
    • 8.2.3. By Animal Type
    • 8.2.4. By Country (United States, Canada, Mexico)
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Animal Pharmaceuticals Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Animal Type
    • 8.3.2. Canada Animal Pharmaceuticals Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Animal Type
    • 8.3.3. Mexico Animal Pharmaceuticals Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Animal Type

9. South America Animal Pharmaceuticals Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Product
    • 9.2.3. By Animal Type
    • 9.2.4. By Country (Brazil, Argentina, Colombia)
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Animal Pharmaceuticals Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Animal Type
    • 9.3.2. Argentina Animal Pharmaceuticals Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Animal Type
    • 9.3.3. Colombia Animal Pharmaceuticals Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Animal Type

10. Middle East and Africa (MEA) Animal Pharmaceuticals Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Product
    • 10.2.3. By Animal Type
    • 10.2.4. By Country (UAE; Saudi Arabia; Qatar, South Africa)
  • 10.3. Middle East and Africa (MEA): Country Analysis
    • 10.3.1. UAE Animal Pharmaceuticals Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Animal Type
    • 10.3.2. Saudi Arabia Animal Pharmaceuticals Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Animal Type
    • 10.3.3. Qatar Animal Pharmaceuticals Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Animal Type
    • 10.3.4. South Africa Animal Pharmaceuticals Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value & Volume
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product Type
        • 10.3.4.2.2. By Product
        • 10.3.4.2.3. By Animal Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Pricing Analysis

14. Patent / FDA Approval Analysis

  • 14.1. New Product Development (NADA, ANADA, CNADA)
  • 14.2. By Company
  • 14.3. Registration Date
  • 14.4. Patent Expiry

15. Competitive Landscape

  • 15.1. Company Profiles (Leading Companies)
    • 15.1.1. Zoetis Inc
    • 15.1.2. Merck Animal Health
    • 15.1.3. Vetoquinol SA
    • 15.1.4. Zoetis Inc
    • 15.1.5. Virbac SA
    • 15.1.6. Boehringer Ingelheim International GmbH
    • 15.1.7. Eli Lilly & Co
    • 15.1.8. Perrigo Co PLC
    • 15.1.9. Sanofi SA
    • 15.1.10. Bayer AG
    • 15.1.11. Elanco Animal Health Inc
    • 15.1.12. Ceva Sante Animale S.A.
    • 15.1.13. Covetrus Inc.
    • 15.1.14. Idexx Laboratories Inc.
    • 15.1.15. Vetoquinol USA, Inc.
    • 15.1.16. Norbrook Laboratories, Ltd.
    • 15.1.17. Huvepharma EOOD
    • 15.1.18. Adivo GmbH
    • 15.1.19. Ceva Sant Animale
    • 15.1.20. Phibro Animal Health Corp.

16. Strategic Recommendations

17. About Us & Disclaimer